These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12774888)

  • 1. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davidson CM; Blohm KL; Hamilton MG
    Hum Exp Toxicol; 2003 May; 22(5):255-61. PubMed ID: 12774888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Hum Exp Toxicol; 2005 Jul; 24(7):347-52. PubMed ID: 16119248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine.
    Duncan EJ; Brown A; Lundy P; Sawyer TW; Hamilton M; Hill I; Conley JD
    J Appl Toxicol; 2002; 22(3):141-8. PubMed ID: 12015792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo decontamination of the nerve agent VX using the domestic swine model.
    Misik J; Pavlik M; Novotny L; Pavlikova R; Chilcott RP; Cabal J; Kuca K
    Clin Toxicol (Phila); 2012 Nov; 50(9):807-11. PubMed ID: 22963275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of localized cooling in the treatment of VX poisoning.
    Sawyer TW; Mikler J; Worek F; Reiter G; Thiermann H; Tenn C; Weatherby K; Bohnert S
    Toxicol Lett; 2011 Jul; 204(1):52-6. PubMed ID: 21530621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
    Mumford H; E Price M; Lenz DE; Cerasoli DM
    Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH; Hattersley IJ; Rutter SJ; Chilcott RP
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F; Foquin A; Briot R; Delacour C; Denis J; Alonso A; Froment MT; Renault F; Lallement G; Masson P
    Toxicology; 2008 Jun; 248(2-3):151-7. PubMed ID: 18450356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
    Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
    Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute pulmonary toxicity following inhalation exposure to aerosolized VX in anesthetized rats.
    Peng X; Perkins MW; Simons J; Witriol AM; Rodriguez AM; Benjamin BM; Devorak J; Sciuto AM
    Inhal Toxicol; 2014 Jun; 26(7):371-9. PubMed ID: 24766293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of kinetic-based computer modelling to evaluate the efficacy of HI 6 in percutaneous VX poisoning.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):74-80. PubMed ID: 16740352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
    Clarkson ED; Schulz SM; Railer RF; Smith KH
    Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.